Searching for Pharmacogenomic Markers: The Synergy between Omic and Hypothesis-Driven Research
With 35,000 genes and hundreds of thousands of protein states to identify, correlate, and understand, it no longer suffices to rely on studies of one gene, gene product, or process at a time. We have entered the “omic” era in biology. But large-scale omic studies of cellular molecules in aggregate r...
Main Author: | John N. Weinstein |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2001-01-01
|
Series: | Disease Markers |
Online Access: | http://dx.doi.org/10.1155/2001/435746 |
Similar Items
-
Evidence of Omics, Immune Infiltration, and Pharmacogenomic for SENP1 in the Pan-Cancer Cohort
by: Somayye Taghvaei, et al.
Published: (2021-07-01) -
Fascial organisation of motor synergies: a hypothesis
by: Alessandro Garofolini, et al.
Published: (2019-08-01) -
Omics-Driven Biotechnology for Industrial Applications
by: Bashar Amer, et al.
Published: (2021-02-01) -
Pharmacogenomic identification of novel markers of response to chemotherapy in colorectal cancer
by: McLean, Estelle Grace
Published: (2006) -
Pharmacogenomics From Basic Research to Clinical Implementation
Published: (2022)